Literature DB >> 7529218

The role of hepatitis C virus in hepatocellular carcinoma in Japan.

S Kaneko1, M Unoura, M Takeuchi, S Terasaki, H Ogino, E Matsushita, K Kobayashi.   

Abstract

Increasing numbers of patients with hepatocellular carcinoma (HCC) have been reported in Japan. In this paper, we investigated the role of hepatitis C virus (HCV) in HCC and the reason for the increase, using patients admitted to our university hospital from 1945 to 1992. 99 (73%) of 135 patients with HCC were positive for anti-HCV. Prospective studies demonstrated that 22 of 158 (14%) patients with chronic hepatitis C, and 31 of 70 (44%) cirrhotic patients with anti-HCV developed to HCC during the follow-up period (10.1 +/- 3.3 and 7.3 +/- 3.5 years, respectively). Prolonged survival of cirrhotic patients during past decades would also contribute to the increasing number of HCC cases as well as the number of HCV infections in Japan.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529218     DOI: 10.1159/000150364

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  3 in total

1.  Predictive value of tumor markers for hepatocarcinogenesis in patients with hepatitis C virus.

Authors:  Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Makoto Tanikawa; Yasuhiro Hisanaga; Akira Kanamori; Toshifumi Tada; Junko Tanaka; Hiroshi Yoshizawa
Journal:  J Gastroenterol       Date:  2010-12-07       Impact factor: 7.527

2.  Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients.

Authors:  Hiromi Saneto; Masahiro Kobayashi; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

3.  HCV infection among Saudi population: high prevalence of genotype 4 and increased viral clearance rate.

Authors:  Ahmed S Abdel-Moneim; Mohammad S Bamaga; Gaber M G Shehab; Abdel-Aziz S A Abu-Elsaad; Fayssal M Farahat
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.